tradingkey.logo
tradingkey.logo
Search

Abbott Plans to Separate Nutrition Business Into Independent Public Company

TradingKeyOct 21, 2026 11:31 AM
facebooktwitterlinkedin
View all comments(0)

Abbott plans to separate its $8.5 billion global Nutrition business into an independent, publicly traded company through a tax-free share distribution to existing shareholders. The transaction is targeted for completion by the end of 2027, contingent upon regulatory approvals, registration statement effectiveness, and final board approval. This strategic move aims to establish the standalone entity as a pure-play leader in the growing healthy nutrition market while streamlining Abbott’s core portfolio operations.

AI-generated summary

Abbott (NYSE: ABT) announced its intention to separate its global Nutrition business into an independent, publicly traded company. The Nutrition business has approximately $8.5 billion in annual sales.

Abbott intends to carry out the separation by distributing shares of the independent Nutrition company to Abbott shareholders. The company described the planned standalone business as a global leader in the rapidly expanding healthy nutrition market.

Abbott expects to complete the transaction by the end of 2027. The planned separation remains subject to customary conditions, including regulatory approvals, the effectiveness of a registration statement on Form 10 and final approval by the Abbott Board of Directors.

This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.